– Rights Offering Was Fully Subscribed –
RICHMOND, Va., December 17, 2021--(BUSINESS WIRE)--Synalloy Corporation (Nasdaq: SYNL) ("Synalloy" or the "Company"), an industrials company focused on the production and distribution of piping, tubing and specialty chemicals, today announced the closing and full subscription of its rights offering that commenced on November 30, 2021 (the "Rights Offering").
The Rights Offering resulted in the sale of a total of 785,103 shares of the Company’s common stock at a price of $12.75 per share. Aggregate gross proceeds from the Rights Offering was approximately $10 million. After giving effect to such new share issuance, the Company has 10,163,458 shares of common stock issued and outstanding as of the date hereof.
A prospectus supplement relating to the Rights Offering was filed with the Securities and Exchange Commission (the "SEC") on November 30, 2021 and is available on the website of the SEC. Subscription rights that were not exercised by 5:00 pm Eastern Daylight Time on December 16, 2021 have expired. Any excess subscription payments received by the Subscription Agent will be returned to the respective holders.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any offer, solicitation or sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Synalloy Corporation (Nasdaq: SYNL) is a company that engages in a number of diverse business activities including the production of stainless steel and galvanized pipe and tube, the master distribution of seamless carbon pipe and tube, and the production of specialty chemicals. For more information about Synalloy Corporation, please visit its web site at www.synalloy.com.
This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties, including without limitation those identified below, which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. The following factors could cause actual results to differ materially from historical results or those anticipated: adverse economic conditions, including risks relating to the impact and spread of and the government’s response to COVID-19; inability to weather an economic downturn; the impact of competitive products and pricing; product demand and acceptance risks; raw material and other increased costs; raw material availability; financial stability of the Company’s customers; customer delays or difficulties in the production of products; loss of consumer or investor confidence; employee relations; ability to maintain workforce by hiring trained employees; labor efficiencies; risks associated with acquisitions; environmental issues; negative or unexpected results from tax law changes; inability to comply with covenants and ratios required by the Company’s debt financing arrangements; and other risks detailed from time-to-time in Synalloy Corporation's Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC. Synalloy Corporation assumes no obligation to update any forward-looking information included in this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211217005097/en/
Company Contact Aaron Tam Chief Financial Officer 1-804-822-3260 Investor Relations Cody Slach and Cody Cree Gateway Investor Relations 1-949-574-3860 SYNL@gatewayir.com Rights Offering Information Agent Saratoga Proxy Consulting, LLC 1-888-368-0379 info@saratogaproxy.com
Wood believes we're still in a strong bull market. Take advantage.
EV stocks are being dumped as a group today, even with these three names reporting good news recently.
More than 90 large-cap stocks are down at least 20% from their 2021 highs, but analysts love many of them, including JD.com, PayPal and Disney.
Buffett is taking profits off the table. It might be time to do the opposite.
Losing money in the S&P 500 is never fun. But it stings all the more when everyone else is making tons on their stocks.
Get aboard the Tesla stock train, argues Dan Ives at Wedbush.
The stock has already managed to settle below the $115 level and is moving towards yearly lows at $108.70.
A cosmetics and skin care products company founded by married Taiwanese actors Zhang Ting and Lin Ruiyang has had assets worth 600 million yuan (US$94 million) frozen due to an investigation by China's market regulator over an alleged pyramid scheme. The market regulator in Shijiazhuang, the capital of northern China's Hebei province, said it had received several reports about a suspected pyramid scheme involving Shanghai Dowell Trading, according to a letter widely circulated on Chinese social
The rally in Victoria's Secret may just be getting started, contends JP Morgan retail analyst Matt Boss.
Biogen, which owns nearly half of a Samsung unit, shares surged Wednesday. A South Korean newspaper reported that Samsung wants to buy Biogen for as much as $42 billion.
What happened Shares of Ocugen (NASDAQ: OCGN) were falling 5.1% as of 12:03 p.m. ET on Wednesday. The company hasn't made any announcements this week. Its stock appears to simply be continuing a slide that began in early November.
(Bloomberg) -- Didi Global Inc. disclosed a $4.7 billion loss after revenues shrank in the September quarter, revealing the rising cost of a series of regulatory actions that will force China’s ride-sharing leader to shift its listing to Hong Kong next year.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Coul
If you want to leave some stocks to your heirs, then you'll want to find companies like these that are poised to thrive for decades to come.
(Bloomberg) -- SenseTime Group Inc. co-founder Tang Xiao’ou has become one of the world’s richest people, after the Chinese AI champion blew past concerns about American sanctions to surge as much as 23% on its Hong Kong debut.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Could Rescue Biden’s AgendaCovid Wi
The worst-performing Dow Jones stocks this year include Walt Disney, Verizon, Merck, Boeing and Honeywell. Disney stock and Verizon saw double-digit percentage losses while the overall Dow Jones stock index finished up 19% for the year.
Berkshire Hathaway is the ultimate Warren Buffett stock. But is it a good buy? Here's what the earnings and chart show for Berkshire stock.
The need of a robust charging infrastructure to support the growth of electric vehicles (EVs) is undisputed. What isn't as clear is which players will be instrumental in developing this infrastructure and, more importantly, whether can they do this profitably. Let's discuss which of the two top EV charging stocks, ChargePoint (NYSE: CHPT) and Blink Charging (NASDAQ: BLNK), is a better buy right now.
Wednesday will go down in history for Codex DNA (NASDAQ: DNAY). The genetics-focused biotech saw its share price rocket 39% higher, thanks to a potentially very lucrative deal with a deep-pocketed pharmaceutical giant. Codex DNA disclosed in a regulatory filing that it has entered into a research collaboration and license agreement with U.S. pharmaceutical company Pfizer (NYSE: PFE), these days best known as the co-developer of the Comirnaty coronavirus vaccine.
China's BYD will look to top the 100,000 vehicles mark, after setting a sixth monthly EV sales record. Nio stock eased.
Since Dec.16, at least 23 analysts have reissued target prices for Alibaba stock. Of those, 17 cut their estimates.